Chloroquine-resistant Plasmodium vivax malaria in Debre Zeit, Ethiopia

Malaria Journal

Volumn 7, Issue , 2008, Pages

  Teka, Hiwot ^a,b   Petros, Beyene ^a   Yamuah, Lawrence ^b   Tesfaye, Gezahegn ^c   Elhassan, Ibrahim ^f   Muchohi, Simon ^d   Kokwaro, Gilbert ^d,e   Aseffa, Abraham ^b   Engers, Howard ^b  

^a ADDIS ABABA UNIVERSITY   (Ethiopia)

^b ARMAUER HANSEN RESEARCH INSTITUTE   (Ethiopia)

^c FEDERAL MINISTRY OF HEALTH   (Ethiopia)

^d KEMRI WELLCOME TRUST RESEARCH PROGRAMME   (Kenya)

^e UNIVERSITY OF NAIROBI   (Kenya)

^f UNIVERSITY OF KHARTOUM   (Sudan)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; DEETHYLCHLOROQUINE; PARACETAMOL; QUININE; ANTIMALARIAL AGENT;

ABDOMINAL PAIN; ADOLESCENT; ADULT; ANOREXIA; ARTHRALGIA; ARTICLE; AXILLA TEMPERATURE; BACKACHE; BLOOD SAMPLING; BLOOD SMEAR; CHILD; CHILL; CLINICAL EXAMINATION; COUGHING; DIARRHEA; DISEASE DURATION; DRUG ABSORPTION; DRUG EFFICACY; ETHIOPIA; FEMALE; FEVER; FOLLOW UP; GIEMSA STAIN; HEADACHE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INFANT; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALARIA; MALE; MYALGIA; PARASITE EXAMINATION; PARASITEMIA; PLASMODIUM VIVAX; RECURRENT INFECTION; RIGOR; SCREENING; TREATMENT FAILURE; TREATMENT RESPONSE; VOMITING; ANIMAL; BLOOD; CHEMISTRY; DRUG EFFECT; DRUG RESISTANCE; MIDDLE AGED; PARASITOLOGY; PLASMODIUM VIVAX MALARIA; PRESCHOOL CHILD; RECURRENT DISEASE; SERUM; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANIMALS; ANTIMALARIALS; BLOOD; CHILD; CHILD, PRESCHOOL; CHLOROQUINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG RESISTANCE; ETHIOPIA; FEMALE; HUMANS; INFANT; MALARIA, VIVAX; MALE; MIDDLE AGED; PARASITEMIA; PLASMODIUM VIVAX; RECURRENCE; SERUM; TREATMENT OUTCOME;

EID: 56349124229     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-7-220     Document Type: Article

References (37)

1. Mapping the global extent of malaria in 2005. CA Guerra RW Snow SI Hay, Trends Parasitol 2006 22 353 358 10.1016/j.pt.2006.06.006 16798089
2. The neglected burden of Plasmodium vivax malaria. K Mendis BJ Sina P Marchesini C Richard, Am J Trop Med Hyg 2001 64 97 106 11425182
3. Federal Ministry of Health, National Five Years Strategic Plan for Malaria Control in Ethiopia: 2001-2005 Malaria and Other Vector-borne Diseases Prevention and Control Team, Diseases Prevention and Control Department, Ministry of Health, Addis Ababa 2005
4. Plasmodium vivax resistant to chloroquine? KH Rieckmann DR Davis DC Hutton, Lancet 1989 2 1183 1184 10.1016/S0140-6736(89)91792-3 2572903
5. Resistance to chloroquine by Plasmodium vivax in Irian Jaya, Indonesia. JK Baird H Basri Purnomo MJ Bangs B Subianto LC Patchen SL Hoffman, Am J Trop Med Hyg 1991 44 547 552 1676566
6. Emergence of chloroquine-resistant Plasmodium vivax in Myanmar (Burma). K Myat Phone O Myint L Myint Z Thaw HA Kyin NY Nwe, Trans R Soc Trop Med Hyg 1993 87 687 10.1016/0035-9203(93)90294-Z 8296378
7. Development of resistance to chloroquine by Plasmodium vivax in Myanmar. T Marlar PK Myat YS Aye KG Khaing S Ma O Mind, Trans R Soc Trop Med Hyg 1995 89 307 308 10.1016/0035-9203(95)90556-1 7660445
8. Chloroquine resistant Plasmodium vivax malaria in India. VK Dua PK Kar VP Sharma, Trop Med Int Health 1996 1 816 819 8980595
9. Chloroquine-resistant Plasmodium vivax in transmigration settlements of West Kalimantan, Indonesia. DJ Fryauff S Tuti A Mardi S Masbar R Patipelohi B Leksana KC Kain MJ Bangs TL Richie JK Baird, Am J Trop Med Hyg 1998 59 513 518 9790420
10. Failure of combined chloroquine and high-dose primaquine therapy for Plasmodium vivax malaria acquired in Guyana, South America. EJ Phillips JS Keystone KC Kain, Clin Infect Dis 1996 23 1171 1173 8922821
11. Plasmodium vivax resistance to chloroquine (R2) and mefloquine (R3) in Brazilian Amazon region. MG Alecrim W Alecrim V Macedo, Rev Soc Bras Med Trop 1999 32 67 68 9927829
12. In-vivo sensitivity of Plasmodium vivax isolates from Rond nia (western Amazon region, Brazil) to regimens including chloroquine and primaquine. JM Villalobos-Salcedo MS Tada E Kimura MJ Menezes LH Pereira da Silva, Ann Trop Med Parasitol 2000 94 749 758 10.1080/00034980020027960 11214093
13. Chloroquine-resistant Plasmodium vivax, Brazilian Amazon. FS de Santana Filho AR Arcanjo YM Chehuan MR Costa FE Martinez-Espinosa JL Vieira MG Barbosa WD Alecrim MG Alecrim, Emerg Infect Dis 2007 13 1125 1126 18214203
14. Plasmodium vivax clinically resistant to chloroquine in Colombia. J Soto J Toledo P Gutierrez M Luzz N Llinas N Cedeno M Dunne J Berman, Am J Trop Med Hyg 2001 65 90 93 11508397
15. Artemisinin or chloroquine for blood stage Plasmodium vivax malaria in Vietnam. GT Phan PJ de Vries BQ Tran HQ Le NV Nguyen TV Nguyen SH Heisterkamp PA Kager, Trop Med Int Health 2002 7 858 864 10.1046/j.1365-3156.2002.00948.x 12358621
16. Chloroquine resistant Plasmodium vivax malaria in Peru. TK Ruebush J Zegarra J Cairo EM Andersen M Green DR Pillai W Marquino M Huilca E Arevalo C Garcia L Solary KC Kain, Am J Trop Med Hyg 2003 69 548 552 14695094
17. Efficacy of chloroquine in the treatment of Plasmodium vivax malaria in Turkey. MA Kurcer Z Simsek FY Zeyrek S Atay H Celik I Kat A Topluoglu, Ann Trop Med Parasitol 2004 98 447 451 10.1179/000349804225021343 15257793
18. Very high risk of therapeutic failure with chloroquine for uncomplicated Plasmodium falciparum and P. vivax malaria in Indonesian Papua. IW Sumawinata BL Bernadeta S Awalludin B Purnomo S Subianto DJ Fryauff JK Baird, Am J Trop Med Hyg 2003 68 416 420 12875290
19. WHO: The use of antimalarial drugs. Reports of WHO informal consultation. WHO/CDS/RBM/2001 33 34 35
20. Efficacy of sulphadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in Ethiopia. D Jima G Tesfaye A Medhin A Kebede D Aragaw O Babaniyi, East Afr Med J 2005 82 8 391 395 16261914
21. Safety and efficacy of artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in Ethiopia. D Jima G Tesfaye A Medhin A Kebede D Aragaw O Babaniyi, East Afr Med J 2005 82 8 387 390 16261913
22. Failure of chloroquine treatment for malaria in the highlands of Ethiopia. NA Tulu RH Webbeg JA Schellenberg DJ Bradley, Trans R Soc Trop Med Hyg 1996 90 556 557 10.1016/S0035-9203(96)90322-3 8944273
23. Central Statistics Agency, Estimate of population size by sex, area and density by region, zone and woreda, July 2007 based on census done in 1994 Addis Ababa 2006
24. National Meteorology Agency, Monthly data of rainfall and temperature from 1996-2006 of Debre Zeit Addis Ababa 2008
25. WHO, Monitoring anti-malarial drug resistance Report of a WHO Consultation Geneva, Switzerland 2002
26. WHO, Management of severe malaria Practical Hand Book 2 2002
27. FMOH, Malaria diagnosis and treatment guidelines for health workers in Ethiopia Addis Ababa 2 2004
28. Diagnosis of resistance to chloroquine by Plasmodium vivax: timing of recurrence and whole blood chloroquine levels. JK Baird B Leksana S Masbar Suradi MA Sutanihardja DJ Fryauff B Subianto, Am J Trop Med Hyg 1997 56 621 626 9230792
29. M Cheesbourgh, District Laboratory practice in Tropical countries Gapsons papers Ltd, NOIDA 2 2000 II
30. British Pharmacopoeia commission, British pharmacopoeia 2004 II
31. Practical HPLC methods for the quantitative determination of common antimalarials in Africa. DJ Bell SK Nyirongo ME Molyneux PA Winstanley SA Ward, J Chromatogr B 2007 847 231 236 10.1016/j.jchromb.2006.10.020
32. Polymorphism at merozoite surface protein-3a locus of Plasmodium vivax: global and local diversity. CM Bruce RM Galinsky JW Barnwell G Snounou KP Day, Am J Trop Med Hyg 1999 61 518 525 10548283
33. Minireview: chloroquine resistance in Plasmodium vivax. JK Baird, Antimicrob Agents Chemother 2004 48 4075 4083 15504824 10.1128/AAC.48.11.4075- 4083.2004
34. Practical PCR genotyping protocols for Plasmodium vivax using Pvcs and Pvmsp1. M Imwong S Pukrittayakamee AC Grüner L Rénia F Letourneur S Looareesuwan NJ White G Snounou, Malaria J 2005 4 20 10.1186/1475-2875-4-20
35. Molecular analysis of strains of Plasmodium vivax from paired primary and relapse infections. AA Craig KC Kain, J Infect Dis 1996 174 373 379 8699069
36. Relapses of Plasmodium vivax infection usually result from activation of heterologous hypnozoites. M Imwong G Snounou S Pukrittayakamee N Tanomsing JR Kim A Nandy JP Guthmann F Nosten J Carlton S Looareesuwan S Nair D Sudimack NP Day TJ Anderson NJ White, J Infect Dis 2007 195 927 933 10.1086/512241 17330781
37. Relapses of Plasmodium vivax infection result from clonal hypnozoites activated at predetermined intervals. N Chen A Auliff K Rieckmann M Gatton Q Cheng, J Infect Dis 2007 195 934 941 10.1086/512242 17330782